Neurocrine slips on failure of depression drug

Published September 16, 2010

Neurocrine slips on failure of depression drug
Shares of Neurocrine Biosciences Inc. fell Wednesday after the company said a depression drug it is developing failed in a midstage clinical trial.
Read more on Channel 8 San Diego